Vivo Opportunity Fund Holdings, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Camp4 Therapeutics Corp Common Stock, par value $0.0001 per share (CAMP)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Camp4 Therapeutics Corp Common Stock, par value $0.0001 per share
Symbol
CAMP
Shares outstanding
52,121,500 shares
Disclosed Ownership
3,856,991 shares
Ownership
7.4%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 18:11:00 UTC
Date of event
31 Dec 2025
Previous filing
17 Sep 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 7.4% 3,856,991 3,856,991 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 7.4% 3,856,991 3,856,991 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 0.8% 389,577 389,577 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity Cayman, LLC, General Partner
Vivo Opportunity Cayman, LLC 0.8% 389,577 389,577 0 /s/ Kevin Dai Kevin Dai/Managing Member